The FDA has approved Amitiza for the treatment of Irritable Bowel Syndrome with Constipation. Since the FDA yanked Zelnorm off the market, patients with IBS have been lacking access to quality treatments.
Amitiza will be marketed by Takeda under license from Sucampo Pharmaceuticals.
Source: FDA
